Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Catalog# ET1610-39
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
-
WB
-
IHC-P
-
IHC-Fr
-
IF-Tissue
-
IF-Cell
-
FC
-
IP
-
Human
-
Mouse
-
Rat
-
HA750215
不含抗保成分
-
Cynomolgus monkey
-
Pig
-
unconjugated
概述
产品名称
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
抗体类型
Recombinant Rabbit monoclonal Antibody
免疫原
Synthetic peptide within C-terminal human Vimentin.
种属反应性
Human, Mouse, Rat (Predicted: Cynomolgus monkey, Pig)
验证应用
WB, IHC-P, IHC-Fr, IF-Tissue, IF-Cell, FC, IP
分子量
Predicted band size: 54 kDa
阳性对照
HeLa cell lysate, HEK-293 cell lysate, Jurkat cell lysate, NIH/3T3 cell lysate, C6 cell lysate, C2C12 cell lysate, RAW264.7 cell lysate, C6, HeLa, L6, C2C12, human endometrial carcinoma tissue, mouse colon tissue, mouse cerebellum tissue, human breast carcinoma tissue, human colon tissue, human kidney tissue, mouse large intestine tissue.
偶联
unconjugated
克隆号
SC60-05
RRID
产品特性
形态
Liquid
存放说明
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
存储缓冲液
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
亚型
IgG
纯化方式
Protein A affinity purified.
应用稀释度
-
WB
-
1:20,000-1:50,000
-
IHC-P
-
1:5,000-1:10,000
-
IHC-Fr
-
1:1,000-1:2,000
-
IF-Tissue
-
1:1,000-1:2,000
-
IF-Cell
-
1:100-1:500
-
FC
-
1:1,000
-
IP
-
Use at an assay dependent concentration.
靶点
功能
Vimentin (57 kDa) is the most ubiquituos intermediate filament protein and the first to be expressed during cell differentiation. All primitive cell types express vimentin but in most non-mesenchymal cells it is replaced by other intermediate filament proteins during differentiation. Vimentin is expressed in a wide variety of mesenchymal cell types: fibroblasts, endothelial cells etc., and in a number of other cell types derived from mesoderm, e.g., mesothelium and ovarian granulosa cells. Vimentin is present in many different neoplasms but is particulary expressed in those originated from mesenchymal cells. Sarcomas e.g., fibrosarcoma, malignt fibrous histiocytoma, angiosarcoma, and leio- and rhabdomyosarcoma, as well as lymphomas, malignant melanoma and schwannoma, are virtually always vimentin positive. Mesoderm derived carcinomas like renal cell carcinoma, adrenal cortical carcinoma and adenocarcinomas from endometrium and ovary usually express vimentin. Also thyroid carcinomas are vimentin positive. Any low differentiated or sarcomatoid carcinoma may express some vimentin. Vimentin is frequently included in the so-called primary panel (together with CD45, cytokeratin, and S-100 protein): Intense staining reaction for vimentin without coexpression of other intermediate filament proteins is strongly suggestive of a mesenchymal tumour or a malignant melanoma. However, in biopsies representing only a sarcomatoid part of renal cell carcinoma a.o. a strong positivity for vimentin without cytokeratin expression may be seen. Tumours like lymphomas and seminomas have the same intermediate filament profile, but the vimentin expression is usually weaker.
背景文献
1. Ridge KM et al. Roles of vimentin in health and disease. Genes Dev. 2022 Apr
2. Kuburich NA et al. Vimentin and cytokeratin: Good alone, bad together. Semin Cancer Biol. 2022 Nov
序列相似性
Belongs to the intermediate filament family.
组织特异性
Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines.
翻译后修饰
Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments. Phosphorylated at Ser-56 by CDK5 during neutrophil secretion in the cytoplasm. Phosphorylated by STK33. Phosphorylated on tyrosine residues by SRMS.; O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status.; S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex.
亚细胞定位
Cytoplasm.
别名
CTRCT30 antibody
Epididymis luminal protein 113 antibody
FLJ36605 antibody
HEL113 antibody
VIM antibody
VIME_HUMAN antibody
Vimentin antibody
图片
-
Application: IHC-Fr
Species: Mouse
Site: Cerebellum
Sample: Frozen section
Antibody concentration: 1/2,000
Antigen retrieval: Not required -
Western blot analysis of Vimentin on different lysates with Rabbit anti-Vimentin antibody (ET1610-39) at 1/20,000 dilution and competitor's antibody at 1/1,000 dilution.
Lane 1: HeLa cell lysate (10 µg/Lane)
Lane 2: HEK-293 cell lysate (10 µg/Lane)
Lane 3: Jurkat cell lysate (10 µg/Lane)
Lane 4: C2C12 cell lysate (10 µg/Lane)
Lane 5: RAW264.7 cell lysate (10 µg/Lane)
Lane 6: C6 cell lysate (10 µg/Lane)
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time: 14 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1610-39) at 1/20,000 dilution and competitor's antibody at 1/1,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of Vimentin on different lysates with Rabbit anti-Vimentin antibody (ET1610-39) at 1/20,000 dilution.
Lane 1: HeLa cell lysate (10 µg/Lane)
Lane 2: HEK-293 cell lysate (10 µg/Lane)
Lane 3: Jurkat cell lysate (10 µg/Lane)
Lane 4: NIH/3T3 cell lysate (10 µg/Lane)
Lane 5: C6 cell lysate (10 µg/Lane)
Lane 6: C2C12 cell lysate (10 µg/Lane)
Lane 7: RAW264.7 cell lysate (10 µg/Lane)
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time: Lane 1-5: 3 seconds; Lane 6-7: 14 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1610-39) at 1/20,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of C6 cells labeling Vimentin with Rabbit anti-Vimentin antibody (ET1610-39) at 1/1,000 dilution and competitor's antibody at 1/200 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Vimentin antibody (ET1610-39) at 1/1,000 dilution and competitor's antibody at 1/200 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of HeLa cells labeling Vimentin with Rabbit anti-Vimentin antibody (ET1610-39) at 1/200 dilution.
Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-Vimentin antibody (ET1610-39) at 1/200 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of L6 cells labeling Vimentin with Rabbit anti-Vimentin antibody (ET1610-39) at 1/50 dilution.
Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-Vimentin antibody (ET1610-39) at 1/50 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. -
☑ Knockout (KO)
All lanes: Western blot analysis of Vimentin with anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
Lane 1: Wild-type Hela whole cell lysate (10 µg).
Lane 2: Vimentin knockout Hela whole cell lysate (10 µg).
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1610-39, 1/5,000) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HA1001) at 1/300,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded mouse colon tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse cerebellum tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat colon tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat cerebellum tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/10,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/10,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human endometrial carcinoma tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human colon tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-Vimentin antibody (ET1610-39) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1610-39) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
☑ Relative expression (RE)
Flow cytometric analysis of HeLa (positive, red) and MCF7 (negative, green) cells labeling Vimentin.
Cells were fixed by 4% formaldehyde and then permeabilized with ice-cold 90% methanol. Then stained with the primary antibody (ET1610-39) at 1/1,000 dilution, compared with Rabbit IgG Isotype Control (HeLa black, MCF7 light green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. -
Vimentin was immunoprecipitated in 0.2mg HeLa cell lysate with ET1610-39 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1610-39 at 1/10,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: HeLa cell lysate (input)
Lane 2: Rabbit IgG instead of ET1610-39 in HeLa cell lysate
Lane 3: ET1610-39 IP in HeLa cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 5 seconds -
Application: IF-tissue
Species: Mouse
Site: Kindey
Sample: Paraffin-embedded section
Antibody concentration: 1/1,000 -
Application: IF-tissue
Species: Mouse
Site: Cerebral cortex
Sample: Paraffin-embedded section
Antibody concentration: 1/1,000
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
引文
-
Super-enhancer-associated LINC00963 promotes metastasis of gastric cancer through epithelial-mesenchymal transition
期刊: Public Library Of Science One
DOI: 10.1371/journal.pone.0332396
IF: 2.6
应用: WB
反应种属: Human
发表时间: 2025 Sept
-
Composition, three-dimensional structure and formation mechanism of the foot and mouth disease virus replication complexes
期刊: Antiviral Research
DOI: 10.1016/j.antiviral.2025.106287
IF: 4
应用: IF-cell
反应种属: Hamster
发表时间: 2025 Oct
-
PDLIM4 drives gastric cancer malignant progression and cisplatin resistance by inhibiting HSP70 ubiquitination and degradation via competitive interaction with STUB1
期刊: Journal Of Nanobiotechnology
DOI: 10.1186/s12951-025-03720-4
IF: 12.6
应用: WB
反应种属: Human
发表时间: 2025 Oct
-
Artemisinin-hydroxychloroquine combination from traditional antimalarial medicine attenuates pulmonary fibrosis via PI3K/AKT/GSK3β-mediated inhibition of epithelial-mesenchymal transition
期刊: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120717
IF: 5.4
应用: WB
反应种属: Rat,Human
发表时间: 2025 Oct
-
The Nano-system Combines Mitochondrial Damage with Microtubule Stabilization for Cancer Metastasis Suppression
期刊: Journal Of Materials Chemistry B
DOI: 10.1039/D5TB01515D
IF: 5.7
应用: WB
反应种属: Mouse
发表时间: 2025 Oct
-
Blastocyst-Secreted miR-519d-3p Modulated the Cell Viability, Apoptosis and Migration of Human Endometrial Stromal Cells by Targeting HIF1α
期刊: Reproductive Sciences
DOI: 10.1007/s43032-025-01988-3
IF: 2.5
应用: IF-Cell
反应种属: Human
发表时间: 2025 Oct
-
ACOD1/Itaconate regulates trophoblast function through the PI3K/Akt/FOLR1 axis to participate in the pathogenesis of recurrent spontaneous abortion
期刊: BIOCHEMICAL PHARMACOLOGY
DOI: 10.1016/j.bcp.2025.117405
IF: 5.6
应用: IHC
反应种属: Mouse
发表时间: 2025 Oct
-
Chlorogenic acid targets STING to alleviate pressure overload-induced heart failure and myocardial fibrosis
期刊: Phytomedicine
DOI: 10.1016/j.phymed.2025.157625
IF: 8.3
应用: mIHC
反应种属: Mouse
发表时间: 2025 Nov
-
Programmed death-ligand 1 mediates triple-negative breast cancer metastasis and stemness through ten-eleven translocation 3
期刊: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2025.148791
IF: 8.5
应用: WB
反应种属: Human
发表时间: 2025 Nov
-
Integrated Analysis of Disulfidptosis-Related Genes Identifies CD2AP as a Potential Therapeutic Target for Hepatocellular Carcinoma
期刊: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
DOI: 10.3390/ijms26094454
IF: 4.9
应用: WB
反应种属: Human
发表时间: 2025 May
-
Hsa_circ_0000479 promotes gastric cancer progression by inhibiting BTRC-mediated ubiquitination of G3BP1
期刊: Experimental Cell Research
DOI: 10.1016/j.yexcr.2025.114585
IF: 3.3
应用: WB
反应种属: Human
发表时间: 2025 May
-
Moderate intensity continuous training mitigates hypertension-induced renal fibrosis by inhibiting HIF-1α-mediated autophagy
期刊: Frontiers In Physiology
DOI: 10.3389/fphys.2025.1529811
IF: 3.2
应用: WB,IF
反应种属: Human,Rat
发表时间: 2025 Mar
-
MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial–mesenchymal transition in hepatocellular carcinoma
期刊: Clinical And Experimental Medicine
DOI: 10.1007/s10238-025-01622-1
IF: 3.2
应用: WB
反应种属: Human
发表时间: 2025 Mar
-
Integrated analysis of single-cell RNA-seq and ATAC-seq in lens epithelial cells: Unveiling the role of ATF6 as a key transcription factor
期刊: Genes & Diseases
DOI: 10.1016/j.gendis.2025.101610
IF: 9.4
应用: WB
反应种属: Mouse
发表时间: 2025 Mar
-
Magnesium ions attenuate tendon graft fibrosis during its ligamentization after ACL reconstruction through modulation of fibroblast to myofibroblast trans-differentiation by promoting PGE2 secretion
期刊: Bioactive Materials
DOI: 10.1016/j.bioactmat.2025.06.019
IF: 20.3
应用: FC
反应种属: Rat
发表时间: 2025 Jun
-
Tumor suppressor SLC9A2 inhibits colorectal cancer metastasis and reverses immunotherapy resistance by suppressing angiogenesis
期刊: Journal Of Experimental & Clinical Cancer Research
DOI: 10.1186/s13046-025-03422-7
IF: 12.8
应用: WB
反应种属: Mouse
发表时间: 2025 Jun
-
WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma
期刊: Advanced Science
DOI: 10.1002/advs.202506529
IF: 14.1
应用: WB
反应种属: Human
发表时间: 2025 Jun
-
A Novel COL12A1 Mutation Causes Oral Tissue Abnormalities by Regulating Gingival Fibroblast Function
期刊: Oral Diseases
DOI: 10.1111/odi.70000
IF: 2.9
应用: IF
反应种属: Human
发表时间: 2025 Jun
-
Engineered Mesenchymal Stem Cell–Derived Extracellular Vesicles Reverse Endothelial–Mesenchymal Transition in Atherosclerosis
期刊: Journal Of Extracellular Vesicles
DOI: 10.1002/jev2.70099
IF: 14.5
应用: IF
反应种属: Mouse
发表时间: 2025 Jun
-
The RNA-binding protein DDX39B promotes colorectal adenocarcinoma progression by stabilizing DCLK1
期刊: HUMAN MOLECULAR GENETICS
DOI: 10.1093/hmg/ddaf110
IF: 3.2
应用: WB
反应种属: Human
发表时间: 2025 Jun
-
An unrecognized mechanism of self-protection in degenerating neurons mediated by astrocytic YAP through Wnts/β-catenin/EAAT2 signaling in C9orf72-poly-GA mice
期刊: Theranostics
DOI: 10.7150/thno.113599
IF: 13.3
应用: IF-Tissue
反应种属: Mouse
发表时间: 2025 Jul
-
Decabromodiphenyl ethane induces intrauterine growth restriction by suppressing placental angiogenesis via TWIST2/NAT10-mediated ac4C-dependent TGF-β1 mRNA stabilization
期刊: Journal Of Hazardous Materials
DOI: 10.1016/j.jhazmat.2025.139377
IF: 11.3
应用: WB,IF
反应种属: Mouse,Human
发表时间: 2025 Jul
-
SPP1 promotes malignant characteristics and drug resistance in hepatocellular carcinoma by activating fatty acid metabolic pathway
期刊: Functional & Integrative Genomics
DOI: 10.1007/s10142-025-01664-4
IF: 3.1
应用: WB
反应种属: Human
发表时间: 2025 Jul
-
Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis
期刊: Journal Of Translational Medicine
DOI: 10.1186/s12967-025-06835-2
IF: 7.5
应用: WB
反应种属: Human
发表时间: 2025 Jul
-
Lithospermic acid improves diabetic kidney fibrosis by regulating Piezo1/TGF-β1/Smad signaling pathway
期刊: European Journal Of Pharmacology
DOI: 10.1016/j.ejphar.2025.177896
IF: 4.7
应用: IF
反应种属: Mouse
发表时间: 2025 Jul
-
Brucea javanica oil inhibited the proliferation, migration, and invasion of oral squamous carcinoma by regulated the MTFR2 pathway
期刊: Frontiers in Oncology
DOI: 10.3389/fonc.2024.1477293
IF: 3.3
应用: WB
反应种属: Human
发表时间: 2025 Jan
-
Brucea javanica oil inhibited the proliferation, migration, and invasion of oral squamous carcinoma by regulated the MTFR2 pathway
期刊: Frontiers In Oncology
DOI:
IF: 3.5
应用: WB
反应种属: Human
发表时间: 2025 Jan
-
Ailanthone inhibits bladder cancer tumor and cell proliferation, epithelial-mesenchymal transition, and activation of the Janus kinase/signal transducer and activator of transcription 3 signaling pathway
期刊: CytoJournal
DOI: 10.25259/Cytojournal_166_2024
IF: 3.1
应用: WB
反应种属: Human
发表时间: 2025 Feb
-
Identification of a Novel Substrate for eEF2K and the AURKA-SOX8 as the Related Pathway in TNBC
期刊: Advanced Science
DOI: 10.1002/advs.202412985
IF: 14.3
应用: IF,WB
反应种属: Human
发表时间: 2025 Feb
-
Neutrophil-Targeting Framework Nucleic Acid Based NETosis-Inhibiting Nanoplatform Orchestrates Intra- and Extra-tumoral Attack to Suppress Primary Tumor and Liver Metastasis
期刊: Advanced Functional Materials
DOI: 10.1002/adfm.202514147
IF: 19
应用: WB,IF,IHC
反应种属: Mouse
发表时间: 2025 Aug
-
A strategy for challenging tumorous bone regeneration by borosilicate bioactive glass boosting moderate magnetic hyperthermia
期刊: Nature Communications
DOI: 10.1038/s41467-025-63270-z
IF: 15.7
应用: WB
反应种属: Human,Rat
发表时间: 2025 Aug
-
Identification and validation of a novel lymph node metastasis-related model for papillary thyroid carcinoma to predict the prognosis
期刊: Gland Surgery
DOI: 10.21037/gs-2025-102
IF: 1.6
应用: WB
反应种属: Human
发表时间: 2025 Aug
-
Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis
期刊: Nature Communications
DOI: 10.1038/s41467-025-61965-x
IF: 15.7
应用: WB
反应种属: Mouse
发表时间: 2025 Aug
-
Integrated bioinformatics analysis screened the key genes and pathways of idiopathic pulmonary fibrosis
期刊: Scientific Reports
DOI: 10.1038/s41598-025-97037-9
IF: 3.8
应用: WB
反应种属: Human
发表时间: 2025 Apr
-
Intestinal microbiota-derived d-(+)-malic acid promotes pBD1 expression via p-p38/ATF1 signaling pathway to maintain porcine intestinal health
期刊: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.114552
IF: 4.8
应用: WB,IF,IHC
反应种属: Mouse
发表时间: 2025 Apr
-
Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium
期刊: Scientific Reports
DOI: 10.1038/s41598-025-99468-w
IF: 3.8
应用: IHC-P
反应种属: Human
发表时间: 2025 Apr
-
The role of apoptosis, immunogenic cell death, and macrophage polarization in carbon ion radiotherapy for keloids: Targeting the TGF-β1/SMADs signaling pathway
期刊: Molecular Basis Of Disease
DOI: https://doi.org/10.1016/j.bbadis.2024.167499
IF:
应用: IHC-P
反应种属: Mouse
发表时间: 2024 Sep
-
Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial–Mesenchymal Transition in Colorectal Cancer
期刊: Digestive Diseases And Sciences
DOI:
IF: 2.5
应用: WB
反应种属: Human
发表时间: 2024 Oct
-
MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1-extracellular signal-regulated kinase-1/2 axis
期刊: World Journal Of Gastrointestinal Oncology
DOI:
IF: 3
应用: WB
反应种属: Human
发表时间: 2024 May
-
ARHGAP4 promotes colon cancer metastasis through the TGF-β signaling pathway and may be associated with T cell exhaustion
期刊: Biochemical And Biophysical Research Communications
DOI:
IF: 3.1
应用: WB
反应种属: Human
发表时间: 2024 May
-
Identification of PRODH as a mitochondria- and angiogenesis-related biomarker for lung adenocarcinoma
期刊: Translational Cancer Research
DOI:
IF: 1.5
应用: WB
反应种属: Human
发表时间: 2024 May
-
IGFBP7 promotes gastric cancer by facilitating epithelial-mesenchymal transition of gastric cells
期刊: Heliyon
DOI:
IF: 4
应用: WB
反应种属: Human
发表时间: 2024 May
-
Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway
期刊: Biochemical Pharmacology
DOI:
IF: 5.8
应用: WB
反应种属: Mouse
发表时间: 2024 Mar
-
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
期刊: Nature Communications
DOI:
IF: 16.6
应用: IF
反应种属: Mouse
发表时间: 2024 Mar
-
Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression
期刊: Cancer Cell International
DOI:
IF: 5.8
应用: WB
反应种属: Mouse
发表时间: 2024 Mar
-
Super-enhancer-associated LINC00963 promotes epithelial-mesenchymal transition in gastric cancer
期刊: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
应用: WB
反应种属: Mouse
发表时间: 2024 Mar
-
FAM188B promotes the growth, metastasis, and invasion of hepatocellular carcinoma by targeting the HRNPA1/PKM2 axis
期刊: Biochimica Et Biophysica Acta - Molecular Cell Research
DOI:
IF: 5.1
应用: WB
反应种属: Human
发表时间: 2024 Jun
-
PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway
期刊: Translational Lung Cancer Research
DOI: 10.21037/tlcr-24-340
IF: 4
应用: WB
反应种属: Human
发表时间: 2024 Jun
-
CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1
期刊: Journal Of Cancer Research And Clinical Oncology
DOI: 10.1007/s00432-024-05837-9
IF: 2.7
应用: WB
反应种属: Human
发表时间: 2024 Jun
-
TNFSF11/TNFRSF11A Axis Amplifies HDM-Induced Airway Remodeling by Strengthening TGFβ1/STAT3 Action
期刊: Allergy Asthma & Immunology Research
DOI:
IF: 4.1
应用: WB,IF
反应种属: Human,Mouse
发表时间: 2024 Jul
-
Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway
期刊: Journal Of Gastric Cancer
DOI:
IF: 3.2
应用: WB
反应种属: Human
发表时间: 2024 Jul
-
circGRHPR inhibits aberrant epithelial-mesenchymal transformation progression of lung epithelial cells associated with idiopathic pulmonary fibrosis
期刊: Cell Biology And Toxicology
DOI:
IF: 6.1
应用: WB
反应种属: Human
发表时间: 2024 Jan
-
miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway
期刊: Toxicology Letters
DOI:
IF: 3.5
应用: WB
反应种属: Human,Mouse
发表时间: 2024 Jan
-
Downregulation of PDZK1 by TGF-β1 promotes renal fibrosis via inducing epithelial-mesenchymal transition of renal tubular cells
期刊: Biochemical Pharmacology
DOI:
IF: 5.8
应用: WB
反应种属: Mouse
发表时间: 2024 Jan
-
OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway
期刊: BMC Cancer
DOI:
IF: 3.8
应用: WB
反应种属: Human
发表时间: 2024 Feb
-
2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione isolated from Averrhoa carambola L. root inhibits high glucose-induced EMT in HK-2 cells through targeting the regulation of miR-21-5p/Smad7 signaling pathway
期刊: Biomedicine & Pharmacotherapy
DOI:
IF: 7.5
应用: WB
反应种属: Human
发表时间: 2024 Feb
-
Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial–mesenchymal transition
期刊: Phytomedicine
DOI:
IF: 7.9
应用: IF
反应种属: Mouse
发表时间: 2024 Feb
-
Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma
期刊: Technology In Cancer Research & Treatment
DOI:
IF: 2.7
应用: WB
反应种属: Human
发表时间: 2024 Dec
-
TAM‐Derived Exosomes Promote EMT by Upregulating lncRNA MIR4435‐2HG in Head and Neck Cancer
期刊: Oral Diseases
DOI:
IF: 2.9
应用: IF
反应种属: Human
发表时间: 2024 Dec
-
Salvianolic acid C promotes renal gluconeogenesis in fibrotic kidneys through PGC1α
期刊: Biochemical And Biophysical Research Communications
DOI: 10.1016/j.bbrc.2024.151174
IF: 2.5
应用: WB
反应种属: Human
发表时间: 2024 Dec
-
Tanshinone I improves renal fibrosis by promoting gluconeogenesis through upregulation of peroxisome proliferator-activated receptor-γ coactivator 1α
期刊: Chronic Kidney Disease And Progression
DOI:
IF: 3
应用: WB
反应种属: Human
发表时间: 2024 Dec
-
Sinomenine Alleviates Rheumatoid Arthritis by Suppressing the PI3K-Akt Signaling Pathway, as Demonstrated Through Network Pharmacology, Molecular Docking, and Experimental Validation
期刊: Drug Design Development And Therapy
DOI:
IF: 4.7
应用: IF
反应种属: Mouse
发表时间: 2024 Aug
-
Quercetin promotes the proliferation, migration, and invasion of trophoblast cells by regulating the miR-149-3p/AKT1 axis
期刊: Kaohsiung Journal Of Medical Sciences
DOI: 10.1002/kjm2.12887
IF: 2.7
应用: WB
反应种属: Human
发表时间: 2024 Aug
-
Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway
期刊: Neuropharmacology
DOI:
IF: 4.6
应用: WB
反应种属: Human
发表时间: 2024 Aug
-
Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway
期刊: American Journal Of Cancer Research
DOI: 10.62347/SQJB1901
IF: 3.6
应用: WB
反应种属: Human
发表时间: 2024 Aug
-
SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma
期刊: Cell Communication And Signaling
DOI:
IF: 8.4
应用: WB
反应种属: Human,Mouse
发表时间: 2024 Apr
-
Modulation of epithelial-mesenchymal transition by gemcitabine: Targeting ionizing radiation-induced cellular senescence in lung cancer cell
期刊: Biochemical Pharmacology
DOI:
IF: 5.8
应用: WB
反应种属: Human
发表时间: 2024 Apr
-
Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution
期刊: Cellular And Molecular Life Sciences
DOI: 10.1007/s00018-023-04961-y
IF: 8
应用: IF
反应种属: Mouse
发表时间: 2023 Sept
-
LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX
期刊: Cell Death Discovery
DOI:
IF: 7
应用: WB
反应种属: Human
发表时间: 2023 Nov
-
DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway
期刊: Thoracic Cancer
DOI:
IF: 2.9
应用: WB
反应种属: Mouse
发表时间: 2023 Nov
-
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665-HMGB1 axis
期刊: Journal Of Gastrointestinal Oncology
DOI:
IF: 2.1
应用: WB
反应种属: Human
发表时间: 2023 Jun
-
Mesenchymal Stem Cells Inhibit Epithelial-to-Mesenchymal Transition by Modulating the IRE1α Branch of the Endoplasmic Reticulum Stress Response
期刊: Stem Cells International
DOI:
IF: 4.3
应用: WB
反应种属: Mouse
发表时间: 2023 Jul
-
Inhibition of Non-small Cell Lung Cancer by Ferroptosis and Apoptosis Induction through P53 and GSK-3β/Nrf2 Signal Pathways using Qingrehuoxue Formula
期刊: Journal Of Cancer
DOI:
IF: 4.478
应用: IHC-P
反应种属: Mouse
发表时间: 2023 Jan
-
Hyaluronic acid mediated Fe3O4 nanocubes reversing the EMT through targeted cancer stem cell
期刊: Colloids And Surfaces B: Biointerfaces
DOI:
IF:
应用: IF,WB
反应种属: Human
发表时间: 2023 Feb
-
Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1 α Feedback Loop
期刊: Analytical Cellular Pathology
DOI:
IF: 4.133
应用: WB,IF-cell
反应种属: Human
发表时间: 2023 Feb
-
Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions
期刊: Tissue & Cell
DOI: 10.1016/j.tice.2023.102284
IF: 2.6
应用: WB
反应种属: Human
发表时间: 2023 Dec
-
Acute myeloid leukemia (AML)‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in AML through IL‐6/JAK2/STAT3 signaling
期刊: Cancer Science
DOI:
IF: 5.7
应用: IF
反应种属: Human
发表时间: 2023 Aug
-
Canonical and noncanonical pyroptosis are both activated in periodontal inflammation and bone resorption
期刊: Journal Of Periodontal Research
DOI: 10.1111/jre.13055
IF: 3.946
应用: IF
反应种属: Human
发表时间: 2022 Sept
-
Hypoxia-Induced HIF-1α Expression Promotes Neurogenic Bladder Fibrosis via EMT and Pyroptosis
期刊: Cells
DOI:
IF: 7.666
应用: WB
反应种属: Rat
发表时间: 2022 Nov
-
LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway
期刊: Biochemical And Biophysical Research Communications
DOI:
IF: 3.322
应用: WB
反应种属: Human
发表时间: 2022 Nov
-
A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages
期刊: Nanoscale
DOI:
IF: 7.790
应用: WB,IF
反应种属: Mouse
发表时间: 2022 Mar
-
Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis
期刊: ACS Applied Nano Materials
DOI:
IF: 15.88
应用: WB
反应种属: Mouse
发表时间: 2022 Dec
-
PlexinA1 activation induced by β2-AR promotes epithelial-mesenchymal transition through JAK-STAT3 signaling in human gastric cancer cells
期刊: Journal Of Cancer
DOI:
IF: 4.207
应用: WB,IF
反应种属: Human
发表时间: 2022 Apr
-
LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
期刊: Frontiers In Oncology
DOI:
IF: 6.24
应用: IHC-P
反应种属: Human
发表时间: 2021 Jun
-
Ginsenoside Rg3 suppresses epithelial-mesenchymal transition via downregulating notch-hes1 signaling in colon cancer cells
期刊: American Journal Of Chinese Medicine
DOI:
IF: 5.7
应用: WB
反应种属: Human
发表时间: 2021 Dec
-
<html><html><html>Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion <i>via</i> Ras/MAPK Signaling Pathway. Frontiers in oncology, 11, 659676.</html></html></html>
期刊: Frontiers In Oncology
DOI:
IF: 4.848
应用: WB,IHC-P
反应种属: Human
发表时间: 2021 Apr
-
Retinal pigment epithelial cells secrete miR-202-5p-containing exosomes to protect against proliferative diabetic retinopathy
期刊: Experimental Eye Research
DOI:
IF: 3.4
应用: IF
反应种属: Human
发表时间: 2020 Dec
同靶点 & 同通路的产品
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05] - BSA and Azide free
Application: WB,IHC-P,IHC-Fr,IF-Tissue,IF-Cell,FC,IP
Reactivity: Human,Mouse,Rat,Cynomolgus monkey,Pig
Conjugate: unconjugated
Vimentin Recombinant Rabbit Monoclonal Antibody [PDH0-01]
Application: WB,IHC-P,IF-Cell,FC,IF-Tissue,mIHC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 647 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 647
Vimentin Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Vimentin Mouse Monoclonal Antibody [D4-B11]
Application: WB,IF-Cell,IHC-P,FC,IF-Tissue,IHC-Fr,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Recombinant Mouse Monoclonal Antibody [A6-C1-R] - BSA and Azide free
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Recombinant Antibody - Rat IgG1 (Chimeric)
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Phospho-Vimentin (S39) Recombinant Rabbit Monoclonal Antibody [JE43-26]
Application: WB,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 488 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 488
Vimentin Recombinant Mouse Monoclonal Antibody [A6-C1-R]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Mouse Monoclonal Antibody [A6-C1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
浙公网安备 33019202000643号